Advertisement

Reactions Weekly

, Volume 1710, Issue 1, pp 173–173 | Cite as

Infliximab

Severe acute infusion reaction, rash and adverse effect on skin: 3 case reports
Case report
  • 22 Downloads

Reference

  1. Binkhorst L, et al. Short article: Switching to a infliximab biosimilar: Short-term results of clinical monitoring in patients with inflammatory bowel disease. European Journal of Gastroenterology and Hepatology 30: 699-703, No. 7, Jul 2018. Available from: URL: https://doi.org/10.1097/MEG.0000000000001113 -Netherlands

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations